EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Happy Pills? The Health Consequences of the Dramatic Increase in Antidepressant Use

Giuliano Masiero, Fabrizio Mazzonna, Sandro Steinbach

The Economic Journal · 11.11.2026

DOI: 10.1093/ej/ueag142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Economic Journal, online erschienen am 11.11.2026. Verfasst von Giuliano Masiero und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This paper examines the health consequences of the rapid increase in antidepressant consumption in Switzerland (2002–2014). Using a shift-share instrumental variable approach, we exploit regional variation in sales driven by product innovation (the shift) and the market power of pharmaceutical firms (the share). Our findings reveal that a one defined daily dose per 1,000 inhabitants increase in antidepressant sales raises hospital admissions for adverse drug reactions by 18% and for depression by 6%. Financial incentives for self-dispensing doctors and reduced access to psychotherapy emerge as key drivers, highlighting concerns about overtreatment and suboptimal prescribing practices.

Zitieren

APA

Masiero, G., Mazzonna, F., & Steinbach, S. (2026). Happy Pills? The Health Consequences of the Dramatic Increase in Antidepressant Use. The Economic Journal. https://doi.org/10.1093/ej/ueag142

Vancouver

Masiero G, Mazzonna F, Steinbach S. Happy Pills? The Health Consequences of the Dramatic Increase in Antidepressant Use. The Economic Journal. 2026. doi:10.1093/ej/ueag142

BibTeX
@article{Masiero2026,
  author = {Masiero, Giuliano and Mazzonna, Fabrizio and Steinbach, Sandro},
  title = {Happy Pills? The Health Consequences of the Dramatic Increase in Antidepressant Use},
  journal = {The Economic Journal},
  year = {2026},
  doi = {10.1093/ej/ueag142}
}
Kostenlos starten →